Habitrol 21 mg
Natural health product licensed in Canada
- Licence holder
- Dr. Reddy's Laboratories Canada Inc.
- NPN or DIN-HM
- 01943073
- Status
- Active licence
- Licence date
- 16 October 2007
- Revision date
- 25 August 2025
- Form
- Timbre transdermique
- Route of administration
- Transdermique
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Triglyceride Caprylique/caprique, methacrylic acid esters (copolymers), Paper, acrylate vinylacetate, Aluminum
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 patch | 1 Tous les jours |
Uses authorised in Canada
Habitrol is indicated as a temporary aid used to facilitate smoking cessation in smokers who strongly desire to give up their smoking habit.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Refer to Attachment 2 in the Legacy.
Source
Official Health Canada record, licence 01943073
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.